Skip to main content
Year archive

POLYNOVO LIMITED — 2005 filings

All 59 regulatory filings released by POLYNOVO LIMITED (PNV) in 2005, sourced directly from the official regulator.

59 Filings
2005 Period
2005 filings (59)
Filing Released Lang
Appendix 3B 7 pages ?Kb
Capital/Financing Update
2005-12-21 English
Change of Director's Interest Notice 2 pages ?Kb
Director's Dealing
2005-12-21 English
Change of Director's Interest Notice 2 pages ?Kb
Director's Dealing
2005-12-21 English
Change of Director's Interest Notice 2 pages ?Kb
Director's Dealing
2005-11-24 English
Change of Director's Interest Notice 2 pages ?Kb
Director's Dealing
2005-11-23 English
Change of Director's Interest Notice 2 pages ?Kb
Director's Dealing
2005-11-17 English
Phase 1 Clinical Trial for Pain Drug - Positive Results 4 pages ?Kb
Capital/Financing Update
2005-11-15 English
CEO to present at Healthcare Conference New York 27 pages ?Kb
Investor Presentation
2005-11-03 English
Appendix 3B 7 pages ?Kb
Share Issue/Capital Change
2005-11-01 English
Change of Director's Interest Notice 2 pages ?Kb
Director's Dealing
2005-11-01 English
Initial Director's Interest Notice 2 pages ?Kb
Director's Dealing
2005-10-30 English
Initial Director's Interest Notice 2 pages ?Kb
Director's Dealing
2005-10-30 English
Chairman's & CEO's AGM Address to Shareholders 46 pages ?Kb
AGM Information
2005-10-27 English
AGM Results 2 pages ?Kb
Declaration of Voting Results & Voting Rights Announcements
2005-10-27 English
Amended Constitution 47 pages ?Kb
Governance Information
2005-10-27 English
Quarterly Investor Update 6 pages ?Kb
Interim / Quarterly Report Q3 2005
2005-10-25 English
Metabolic ranks number 1 as Australia's top innovator 2 pages ?Kb
Regulatory Filings
2005-10-23 English
CEO to present at Healthcare & Life Science Conference 2 pages ?Kb
Investor Presentation
2005-10-18 English
Starts next clinical trial of obesity drug 3 pages ?Kb
Regulatory Filings
2005-10-17 English
Presentation at the NAASO - Obesity Society Conference 2 pages ?Kb
Investor Presentation
2005-10-17 English
CEO to present at Wilson HTM Biotechnology Conference 2 pages ?Kb
Investor Presentation
2005-10-09 English
Appointment of Non-Executive Director 2 pages ?Kb
Board/Management Information
2005-10-04 English
Release of Securities from Escrow-Monash Investment HldgsP/L 1
Major Shareholding Notification
2005-09-26 English
Annual Report & Notice of AGM 69 pages ?Kb
AGM Information
2005-09-26 English
Metabolic CEO to Present at Biotechnology Conference 2 pages ?Kb
Investor Presentation
2005-09-06 English
Change of Director's Interest Notice 2 pages ?Kb
Director's Dealing
2005-08-31 English
Preliminary Final Report 34 pages ?Kb
Annual Report FY 2005
2005-08-25 English
Appoints new CFO 2 pages ?Kb
Board/Management Information
2005-08-22 English
Pain Drug ACV1 - Clinical Trial Update 2 pages ?Kb
Regulatory Filings
2005-08-14 English
Appendix 3B 7 pages ?Kb
Capital/Financing Update
2005-08-07 English
Change of Director's Interest Notice 2 pages ?Kb
Director's Dealing
2005-08-03 English
Change of Director's Interest Notice 2 pages ?Kb
Director's Dealing
2005-08-03 English
Change of Director's Interest Notice 2 pages ?Kb
Director's Dealing
2005-08-03 English
Appendix 3B 7 pages ?Kb
Capital/Financing Update
2005-07-27 English
Share Purchase Plan Results 2 pages ?Kb
Capital/Financing Update
2005-07-20 English
Investor Update 5 pages ?Kb
Investor Presentation
2005-07-04 English
VP Corporate Development Position 1 page ?Kb
Board/Management Information
2005-06-23 English
Share Purchase Plan Offer to Shareholders 6 pages ?Kb
Capital/Financing Update
2005-06-23 English
Notice under Section 708A of the Corps Act 1 page ?
Capital/Financing Update
2005-06-23 English
Change in substantial holding 2 pages ?Kb
Major Shareholding Notification
2005-06-23 English
ACV1 Neuropathic Pain Drug Phase 1 Clinical Trial Starts 2 pages ?Kb
Regulatory Filings
2005-06-22 English
Appendix 3B 7 pages ?Kb
Capital/Financing Update
2005-06-22 English
Placement of $10M & $10M Share Purchase Plan Offer 2 pages ?Kb
Capital/Financing Update
2005-06-13 English
Reinstatement to Official Quotation 1 page ?Kb
Capital/Financing Update
2005-06-13 English
AusIndustry commercial ready grant of ACV1 2 pages ?Kb
Capital/Financing Update
2005-06-13 English
Conference Presentations 1 page ?Kb
Investor Presentation
2005-06-13 English
Suspension from Official Quotation 1 page ?Kb
Delisting Announcement
2005-06-09 English
Trading Halt 1 page ?Kb
Regulatory Filings
2005-06-07 English
AOD9604 Obesity Drug Update 3 pages ?Kb
Capital/Financing Update
2005-06-02 English
Establishes American Depositary Receipt Program 7 pages ?Kb
Capital/Financing Update
2005-05-31 English
Response to ASX Share Price Query 5 pages ?Kb
Regulatory Filings
2005-05-19 English
ACV1 Update 2 pages ?Kb
Investor Presentation
2005-05-01 English
AOD9604 Update 5 pages ?Kb
Regulatory Filings
2005-04-19 English
Investor Update 6 pages ?Kb
Investor Presentation
2005-03-07 English
US Presentations 44 pages ?Kb
Investor Presentation
2005-02-21 English
Half Yearly Report & Accounts 15 pages ?Kb
Interim / Quarterly Report H1 2005
2005-02-20 English
CEO to speak on Obesity Panel at BIO CEO Conference 1
Regulatory Filings
2005-02-09 English
Appoints new Chief Executive Officer - Dr Roland Scollay 3 pages ?Kb
Board/Management Information
2005-01-23 English
CEO Position 1 page ?Kb
Board/Management Information
2005-01-12 English